WELLS FARGO & COMPANY/MN - MOLECULIN BIOTECH INC ownership

MOLECULIN BIOTECH INC's ticker is MBRX and the CUSIP is 60855D101. A total of 2 filers reported holding MOLECULIN BIOTECH INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of MOLECULIN BIOTECH INC
ValueSharesWeighting
Q4 2020$0
-100.0%
378
-99.5%
0.00%
Q3 2020$67,000
-11.8%
82,518
+5.8%
0.00%
Q2 2020$76,00077,986
+8469.9%
0.00%
Q1 2020$0
-100.0%
910
-70.9%
0.00%
Q4 2019$3,0000.0%3,1320.0%0.00%
Q3 2019$3,0000.0%3,132
+25.3%
0.00%
Q2 2019$3,000
-66.7%
2,500
-50.0%
0.00%
Q1 2018$9,0005,0000.00%
Other shareholders
MOLECULIN BIOTECH INC shareholders Q1 2021
NameSharesValueWeighting ↓
Whitegate Investment Counselors, Inc. 101,781$81,0000.01%
Levy Wealth Management Group, LLC 14,036$11,0000.01%
WOODMONT INVESTMENT COUNSEL LLC 12,000$10,0000.00%
Renaissance Technologies 948,503$756,0000.00%
Qube Research & Technologies Ltd 132,238$105,0000.00%
Core Wealth Advisors, Inc. 1,711$1,0000.00%
UBS Group AG 36,726$29,0000.00%
IFP Advisors, Inc 0$00.00%
Squarepoint Ops LLC 12,342$10,0000.00%
TRUE Private Wealth Advisors 2,500$1,0000.00%
View complete list of MOLECULIN BIOTECH INC shareholders